Beta-blockers show no benefit for heart attack patients with

The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.

Related Keywords

New Zealand , Estonia , Canada , Sweden , Canadian , Swedish , , Canadian Cardiovascular Society , New England Journal , Randomized Evaluation , Decreased Usage , Acute Myocardial Infarction , Myocardial Infarction , Preserved Ejection , Image Credit , Swedish Web System , Evidence Based Care , Heart Disease Evaluated According , Recommended Therapies , Heart , Heart Attack , Angiography , Asthma , Bradycardia , Cardiovascular Disease , Efficacy , Heart Disease , Heart Failure , Hospital , Hypotension , Medicine , Ortality , Pacemaker , Research , Stroke ,